{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T18:38:17Z","timestamp":1785523097355,"version":"3.56.0"},"reference-count":36,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:00:00Z","timestamp":1785456000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013885","name":"Kementerian Kesihatan Malaysia","doi-asserted-by":"publisher","award":["NMRR ID-24-00853-YHT"],"award-info":[{"award-number":["NMRR ID-24-00853-YHT"]}],"id":[{"id":"10.13039\/501100013885","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Diabetes is a major health concern in Malaysia, yet no comprehensive review has assessed the quality of care for these patients. This study aims to systematically review published evidence on type 2 diabetes mellitus (T2DM) management in Malaysian primary health care (PHC), focusing on the achievement of glycated haemoglobin (HbA1c), blood pressure (BP), and LDL-cholesterol (LDL-C) targets (ABC control).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A scoping review was conducted, involving a comprehensive search of four databases (PubMed, Embase, Scopus, and MyMedR) and grey literature for publications up to December 2024. Studies were included if they reported on at least one ABC indicator among the general adult T2DM population in Malaysian PHC settings. The scoping review followed the Joanna Briggs Institute (JBI) methodology and PRISMA-ScR guidelines. EndNote was used for deduplication, and Rayyan was utilised for the screening process. Data were extracted and synthesised narratively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 109 publications were included. Publications increased post-2010 but remained geographically concentrated in urban states. Large-scale studies heavily relied on the National Diabetes Registry. HbA1c was the most reported indicator. Findings revealed no evidence of improvement in HbA1c and BP control over two decades; achievement rates were 30\u201345% for HbA1c (&lt;7.0%) and 20\u201350% for combined BP target (&lt;130\/80 mmHg). Conversely, LDL-C control (\u22642.6 mmol\/L) showed a modest improvement, with achievement rates rising from approximately 30% to 50% over a decade.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Despite a substantial increase in research, the HbA1c and BP control for T2DM in Malaysian PHC has remained static and suboptimal, highlighting a persistent gap between clinical guidelines and real-world outcomes. The modest improvement in LDL-C suggests that progress is achievable. These findings underscore the need for a balanced policy focus on all three ABC indicators, strategies to overcome systemic barriers, and continued investment in the national registry to guide evidence-based improvements in diabetes care.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0355227","type":"journal-article","created":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T17:22:41Z","timestamp":1785518561000},"page":"e0355227","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["The quality of care for type 2 diabetes mellitus management in Malaysian primary health care settings: A scoping review of ABC (glycated haemoglobin A1c, blood pressure, and LDL-cholesterol)"],"prefix":"10.1371","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9170-2099","authenticated-orcid":true,"given":"Mohamad Zulfikrie","family":"Abas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-9042-5618","authenticated-orcid":true,"given":"Norshahiratul Atiqah","family":"Mohd Zaidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei Jia","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin Rou","family":"Teh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim Sui","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azah Abdul","family":"Samad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan Keat","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2314-6048","authenticated-orcid":true,"given":"Sheamini","family":"Sivasampu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6676-6269","authenticated-orcid":true,"given":"Swee Hung","family":"Ang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,7,31]]},"reference":[{"issue":"1","key":"pone.0355227.ref001","doi-asserted-by":"crossref","first-page":"14790","DOI":"10.1038\/s41598-020-71908-9","article-title":"Global, regional, and national burden and trend of diabetes in 195 countries and territories: an analysis from 1990 to 2025","volume":"10","author":"X Lin","year":"2020","journal-title":"Sci Rep"},{"key":"pone.0355227.ref002","volume-title":"IDF diabetes atlas","author":"International Diabetes Federation","year":"2025"},{"key":"pone.0355227.ref003","volume-title":"National Health and Morbidity Survey (NHMS) 2023: Non-Communicable Diseases and Healthcare Demand: Technical Report","author":"Ministry of Health Malaysia","year":"2024"},{"key":"pone.0355227.ref004","article-title":"Variations in the Delivery of Primary Diabetes Care in Malaysia: Lessons to Be Learnt and Potential for Improvement","volume":"7","author":"FI Mustapha","year":"2020","journal-title":"Health Serv Res Manag Epidemiol"},{"key":"pone.0355227.ref005","volume-title":"Clinical Practice Guidelines: Management of Type 2 Diabetes Mellitus (6th Edition)","author":"Ministry of Health Malaysia","year":"2020"},{"key":"pone.0355227.ref006","article-title":"4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Care in Diabetes-2024","volume":"47","author":"American Diabetes Association Professional Practice Committee","year":"2024","journal-title":"Diabetes Care"},{"key":"pone.0355227.ref007","volume-title":"National Diabetes Registry Report 2023","author":"Ministry of Health Malaysia","year":"2024"},{"issue":"3","key":"pone.0355227.ref008","first-page":"175","article-title":"The status of diabetes control in Malaysia: results of DiabCare 2008","volume":"66","author":"M Mafauzy","year":"2011","journal-title":"Med J Malaysia"},{"issue":"11","key":"pone.0355227.ref009","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1111\/1753-0407.13206","article-title":"Changes in body mass index, glycosylated hemoglobin A1C, blood pressure, and LDL-cholesterol among type 2 diabetes patients in Malaysia: A population-based longitudinal study","volume":"13","author":"KS Wan","year":"2021","journal-title":"J Diabetes"},{"issue":"10","key":"pone.0355227.ref010","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.11124\/JBIES-20-00167","article-title":"Updated methodological guidance for the conduct of scoping reviews","volume":"18","author":"MDJ Peters","year":"2020","journal-title":"JBI Evid Synth"},{"issue":"7","key":"pone.0355227.ref011","doi-asserted-by":"crossref","first-page":"467","DOI":"10.7326\/M18-0850","article-title":"PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation","volume":"169","author":"AC Tricco","year":"2018","journal-title":"Ann Intern Med"},{"key":"pone.0355227.ref012","volume-title":"National Strategic Plan for Non-Communicable Disease (NSP-NCD) 2016-2025","author":"Ministry of Health Malaysia","year":"2016"},{"issue":"6","key":"pone.0355227.ref013","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.aogh.2015.12.016","article-title":"Diabetes care in Malaysia: problems, new models, and solutions","volume":"81","author":"Z Hussein","year":"2015","journal-title":"Ann Glob Health"},{"issue":"4","key":"pone.0355227.ref014","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.3390\/ijerph20043147","article-title":"Spatial Accessibility of Primary Care in the Dual Public-Private Health System in Rural Areas, Malaysia","volume":"20","author":"J Ab Hamid","year":"2023","journal-title":"Int J Environ Res Public Health"},{"issue":"2","key":"pone.0355227.ref015","article-title":"Chasm in primary care provision in a universal health system: Findings from a nationally representative survey of health facilities in Malaysia","volume":"12","author":"HM Lim","year":"2017","journal-title":"PLoS One"},{"key":"pone.0355227.ref016","volume-title":"Manual pengguna audit klinikal diabetes di fasiliti kesihatan","author":"Ministry of Health Malaysia","year":"2008"},{"key":"pone.0355227.ref017","volume-title":"National Diabetes Registry Report, Volume 1, 2009-2012","author":"MI Feisul","year":"2013"},{"key":"pone.0355227.ref018","article-title":"Five-year LDL-cholesterol trend and its predictors among type 2 diabetes patients in an upper-middle-income country: a retrospective open cohort study","volume":"10","author":"KS Wan","year":"2022","journal-title":"PeerJ"},{"issue":"1","key":"pone.0355227.ref019","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s40200-025-01620-w","article-title":"Unravelling the association of glycosylated haemoglobin A1c, blood pressure, and LDL-cholesterol (ABC) with all-cause mortality in Type 2 diabetes patients: insights from a middle-income country","volume":"24","author":"MZ Abas","year":"2025","journal-title":"J Diabetes Metab Disord"},{"key":"pone.0355227.ref020","volume-title":"SIQ investigation quality of diabetes care at MOH healthcare facilities: glycaemic control","author":"Ministry of Health Malaysia","year":"2008"},{"issue":"9","key":"pone.0355227.ref021","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.2337\/dci17-0026","article-title":"Diabetes and Hypertension: A Position Statement by the American Diabetes Association","volume":"40","author":"IH de Boer","year":"2017","journal-title":"Diabetes Care"},{"issue":"3","key":"pone.0355227.ref022","article-title":"Blood pressure control, risk factors and cardiovascular prognosis in patients with diabetes: 30 years of progress","volume":"26","author":"J-J Mourad","year":"2008","journal-title":"J Hypertens Suppl"},{"key":"pone.0355227.ref023","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s13098-018-0377-7","article-title":"Combined effect of glycemic and blood pressure control on diabetic retinopathy among Chinese with type-2 diabetes mellitus","volume":"10","author":"C-W Pan","year":"2018","journal-title":"Diabetol Metab Syndr"},{"issue":"10","key":"pone.0355227.ref024","article-title":"Clinical inertia in type 2 diabetes management in a middle-income country: A retrospective cohort study","volume":"15","author":"KS Wan","year":"2020","journal-title":"PLoS One"},{"key":"pone.0355227.ref025","doi-asserted-by":"crossref","first-page":"2980250","DOI":"10.1155\/2022\/2980250","article-title":"Determinants of Poor Treatment Adherence among Patients with Type 2 Diabetes and Limited Health Literacy: A Scoping Review","volume":"2022","author":"N Pourhabibi","year":"2022","journal-title":"J Diabetes Res"},{"issue":"6","key":"pone.0355227.ref026","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2022.e09716","article-title":"Factors influencing poor medication adherence amongst patients with chronic disease in low-and-middle-income countries: A systematic scoping review","volume":"8","author":"GD Chauke","year":"2022","journal-title":"Heliyon"},{"issue":"1","key":"pone.0355227.ref027","first-page":"269","article-title":"Factors affecting therapeutic compliance: A review from the patient\u2019s perspective","volume":"4","author":"J Jin","year":"2008","journal-title":"Ther Clin Risk Manag"},{"key":"pone.0355227.ref028","doi-asserted-by":"crossref","first-page":"137","DOI":"10.2147\/TCRM.S182716","article-title":"Effectiveness and prescription pattern of lipid-lowering therapy and its associated factors among patients with type 2 diabetes mellitus in Malaysian primary care settings","volume":"15","author":"MH Elnaem","year":"2019","journal-title":"Ther Clin Risk Manag"},{"key":"pone.0355227.ref029","volume-title":"Clinical Practice Guidelines: Management of Type 2 Diabetes Mellitus","author":"Ministry of Health Malaysia","year":"2015"},{"key":"pone.0355227.ref030","volume-title":"Clinical Practice Guidelines: Management of Type 2 Diabetes Mellitus","author":"Ministry of Health Malaysia","year":"2009"},{"key":"pone.0355227.ref031","volume-title":"Clinical practice guidelines: Management of type 2 diabetes mellitus (3rd edition)","author":"Ministry of Health Malaysia","year":"2004"},{"key":"pone.0355227.ref032","article-title":"Standard of Care in Diabetes - 2023","volume":"46","author":"American Diabetes Association","year":"2022","journal-title":"The Journal of Clinical and Applied Research and Education"},{"key":"pone.0355227.ref033","volume-title":"Type 2 Diabetes in Adults: Management","author":"National Institute for Health and Care Excellence","year":"2015"},{"issue":"1","key":"pone.0355227.ref034","doi-asserted-by":"crossref","first-page":"182","DOI":"10.3390\/medicina59010182","article-title":"Clinical Inertia in the Management of Type 2 Diabetes Mellitus: A Systematic Review","volume":"59","author":"TH Almigbal","year":"2023","journal-title":"Medicina (Kaunas)"},{"issue":"8","key":"pone.0355227.ref035","article-title":"Quality of hypertension management in public primary care clinics in Malaysia: An update","volume":"15","author":"XR Teh","year":"2020","journal-title":"PLoS One"},{"issue":"1","key":"pone.0355227.ref036","doi-asserted-by":"crossref","first-page":"12625","DOI":"10.1038\/s41598-024-63617-4","article-title":"Treatment intensification and therapeutic inertia of antihypertensive therapy among patients with type 2 diabetes and hypertension with uncontrolled blood pressure","volume":"14","author":"KS Wan","year":"2024","journal-title":"Sci Rep"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0355227","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T17:22:51Z","timestamp":1785518571000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0355227"}},"subtitle":[],"editor":[{"given":"Mahmoud M","family":"Werfalli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,7,31]]},"references-count":36,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7,31]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0355227","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,31]]}}}